ClinConnect ClinConnect Logo
Search / Trial NCT06062472

Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

Launched by CHI-CHANG HUANG · Sep 25, 2023

Trial Information

Current as of April 26, 2025

Completed

Keywords

ClinConnect Summary

Taiwan has become an aging society in recent years. There are important issues to attenuate aging and activate the potential capacity of elderly population. The physical function of middle-aged and older people will degenerate with age and produce age-related diseases. Common symptoms are organ function deterioration, and old age disability caused by malnutrition and muscle loss is also a common care problem. Therefore, how to prevent the complications of muscle loss is one of the important ten years of geriatric research. Although past research has been confirmed, it can improve the debili...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age between 65 and 85 years old
  • Exclusion Criteria:
  • Have taken antibiotics within one month or are receiving antibiotic treatment
  • Have used probiotic products in powder, capsule or tablet form within two weeks (except for yogurt, yogurt, Yakut and other related foods)
  • People allergic to lactic acid bacteria products
  • Patients diagnosed with stroke or hypertension (systolic blood pressure greater than 139, diastolic blood pressure greater than 89)
  • Exclusion of limbs and hips that have been replaced with artificial joints
  • Persons with incapacity/insufficient decision-making ability
  • Who has been determines that it is not suitable to participate in the research.

About Chi Chang Huang

Chi-Chang Huang is a dedicated clinical trial sponsor with a robust commitment to advancing healthcare through innovative research. With a focus on developing new therapies and improving patient outcomes, Huang leads initiatives that prioritize scientific rigor and ethical standards. His extensive experience in clinical trial management encompasses various therapeutic areas, fostering collaborations with healthcare professionals, regulatory bodies, and research institutions. Through a patient-centered approach, Chi-Chang Huang aims to bridge the gap between scientific discovery and clinical application, ultimately contributing to the enhancement of global health.

Locations

Taoyuan, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported